Ucsf brain tumor clinical trial

We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research. Summary Eligibility for people ages full criteria Location at San Francisco, California and other locations Dates study started August Pamela Munster. Eligibility You can join if… Open to people ages Men or women greater than or equal to 18 years old. Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.

G12C mutation identified through molecular testing. Safety studies in humans have proven that magrolimab has an excellent safety profile. Ongoing studies are currently testing magrolimab in adult myelodysplastic syndromes, acute myeloid leukemia, non-Hodgkin lymphoma, colorectal, ovarian, and bladder cancers. Herein we propose to test the safety of magrolimab in children and adults with recurrent or progressive malignant brain tumors.

Last updated: December 14, Showing trials for All Female Male. We are also part of several national consortia to conduct clinical trials at multiple centers across the country. Our involvement in national cooperative clinical trials ensures that our patients have access to the latest techniques and the newest concepts for treatment of brain tumors:. Clinical trials are research studies that evaluate whether a new investigational treatment is safe and effective to use.

Although researchers do not know in advance how effective an investigational treatment may be, new drugs or procedures must have shown some potential for success before a trial is approved. This may include insights from laboratory research, animal studies, or earlier clinical trials. Clinical trials are structured into phases to answer specific questions.